Unity Looks Ahead To Pivotal Study With Positive DME Data For UBX1325

 
• By Alaric DeArment
Unity Biotechnology announced data from the Phase II BEHOLD trial in DME • Source: Shutterstock

More from Clinical Trials

More from R&D